tiprankstipranks
Trending News
More News >
Waverley Pharma (TSE:WAVE)
:WAVE
Canadian Market

Waverley Pharma (WAVE) Financial Statements

Compare
5 Followers

Waverley Pharma Financial Overview

Waverley Pharma's market cap is currently C$540.00K. The company's EPS TTM is C$; its P/E ratio is ―; Waverley Pharma is scheduled to report earnings on May 22, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 79.80K$ 581.78K$ 222.67K$ 181.71K$ 48.94K
Operating Income$ -2.23M$ -638.16K$ -786.83K$ -709.60K$ -1.41M
EBITDA$ -1.72M$ -435.33K$ -726.25K--
Net Income$ -2.22M$ -664.08K$ -796.51K$ -705.76K$ -1.21M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 952.29K$ 2.69M$ 3.68M$ 3.49M$ 4.39M
Total Debt$ 1.60M$ 701.73K$ 262.36K$ 40.00K$ 0.00
Net Debt$ 1.55M$ 567.93K$ 104.24K$ -670.49K$ -1.48M
Total Liabilities$ 2.09M$ 1.60M$ 1.89M$ 1.45M$ 1.55M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -1.02M$ -237.06K$ -798.78K$ -361.70K$ -1.41M
Operating Cash Flow$ -1.02M$ -237.06K$ -798.78K$ -361.70K$ -1.41M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Waverley Pharma Earnings and Revenue History

Waverley Pharma Debt to Assets

Waverley Pharma Cash Flow

Waverley Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis